Christianson Gary 4
4 · Cascadian Therapeutics, Inc. · Filed Feb 2, 2018
Insider Transaction Report
Form 4
Christianson Gary
Chief Operating Officer
Transactions
- Award
Restricted Share Unit (RSU)
2018-02-01+164,500→ 164,500 totalExp: 2022-02-01→ Common Stock (164,500 underlying)
Footnotes (2)
- [F1]Approximately 70% of each RSU represents a contingent right to receive approximately 0.70 share of the issuer's Common Stock upon vesting and approximately 30% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate the holder's satisfaction of U.S. federal tax obligations in connection with the vesting of the RSUs.
- [F2]Twenty-five percent of the shares underlying the RSU vest on each of February 1, 2019, February 1, 2020, February 1, 2021 and February 1, 2022, subject to the holder's continued employment with the issuer on each vesting date.